Patents by Inventor Jonas Adriansson

Jonas Adriansson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6986889
    Abstract: The present invention relates to a novel drug candidate having a potential for universal therapy of allergy and asthma. The invention provides a Fab (antibody fragment), having the following characteristics: a) inhibits the IgE-Fc?RI interaction; b) binds to free and cell-bound IgE; and c) is non-anaphylactic.
    Type: Grant
    Filed: March 28, 2002
    Date of Patent: January 17, 2006
    Assignee: Pharmacia Diagnostics AB
    Inventors: Sylvia Laffer, Erik Högbom, Kenneth H. Roux, Jonas Adriansson, Wolfgang R. Sperr, Peter Valent, Dietrich Kraft, Hans Grönlund, Rudolf Valenta
  • Publication number: 20030035796
    Abstract: The present invention relates to a novel drug candidate having a potential for universal therapy of allergy and asthma.
    Type: Application
    Filed: March 28, 2002
    Publication date: February 20, 2003
    Applicant: Pharmacia Deagnostics AB
    Inventors: Sylvia Laffer, Erik Hogbom, Kenneth H. Roux, Jonas Adriansson, Wolfgang R. Sperr, Peter Valent, Dietrich Kraft, Hans Gronlund, Rudolf Valenta
  • Patent number: RE42324
    Abstract: The present invention relates to a novel drug candidate having a potential for universal therapy of allergy and asthma. The invention provides a Fab (antibody fragment), having the following characteristics: a) inhibits the IgE-Fc?RI interaction; b) binds to free and cell-bound IgE; and c) is non-anaphylactic.
    Type: Grant
    Filed: April 9, 2010
    Date of Patent: May 3, 2011
    Assignee: Phadia AB
    Inventors: Sylvia Laffer, Erik Hogbom, Kenneth H. Roux, Jonas Adriansson, Wolfgang R. Sperr, Peter Valent, Dietrich Kraft, Hans Grönlund, Rudolf Valenta